Merck & Co., Inc.
Foreign stocks · NYSE · Healthcare · Pharmaceuticals
A US drug company that earns almost half its revenue from a single cancer drug, Keytruda, followed by vaccines and animal health products
For every 100 dollars of sales: cost of sales 25 · operating expenses 42 · tax and other items 5 · leaving 28 as net profit
Investors in Thailand can buy MRK through 38 mutual funds open to retail investors. Most of them (38 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds MRK.
| Fund | MRK weight | How it invests | 1-year return |
|---|---|---|---|
 SCBIHEALT(SSFE)SCB Healthcare Innovation | 6.49% | Via BNP Paribas Funds Health Care Innovators | +15.53% |
 LHHEALTH-A |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
| Master fund | Thai funds using this route | Master fund's MRK weight |
|---|---|---|
| Janus Henderson Global Life Sciences Fund | 7 | 2.38% |
| AB Low Volatility Equity Portfolio | 4 | 1.94% |
| United Global Healthcare Fund | 3 | 5.54% |
| Wellington Global Health Care Equity Fund | 3 | 5.47% |
| 6.22% |
| Via AB International Health Care Portfolio |
| +18.58% |
 MHEALTHGMFC Health Innovation Fund | 6.03% | Via BGF World Healthscience Fund | +17.59% |
| MHEALTHRMFMFC Health Innovation Retirement Fund | 5.90% | Via BGF World Healthscience Fund | +18.34% |
 TUSHEALTH-ATISCO US Healthcare Fund | 5.77% | Via XLV | +23.08% |
 UHCRMFUnited Global Healthcare RMF | 5.54% | Via United Global Healthcare Fund | +15.57% |
| UGHUnited Global Healthcare Fund | 5.49% | Via United Global Healthcare Fund | +15.64% |
| UOBSHCUOB Smart Global Healthcare Fund | 5.49% | Via United Global Healthcare Fund | +15.82% |
 BCARERMFBualuang Global Health Care RMF | 5.47% | Via Wellington Global Health Care Equity Fund | +22.64% |
| BCAREBualuang Global Health Care Fund | 5.46% | Via Wellington Global Health Care Equity Fund | +23.02% |
Yearly average over the last 4 years · Latest annual sales 65.0B USD
For every 100 dollars of sales, about 28 dollars is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now 5.0% below its 1-year high
| Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue | 48.7B USD | 59.3B USD | 60.1B USD | 64.2B USD | 65.0B USD |
| Gross profit | 35.1B USD | 41.9B USD | 44.0B USD | 49.0B USD | 48.6B USD |
| Net profit |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 145.33 | 146.16 | Above |
| 20 days | 145.45 | 145.74 | Above |
| 50 days | 146.50 | 143.98 | Above |
| 100 days | 137.92 | 138.40 | Above |
| 200 days |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 54.53 | Up |
| MACD(12,26) | 0.44 | Up |
| ADX(14) | 13.91 | Neutral |
| ATR(14) % of price | 1.72 | Neutral |
SCBAM5
KTAM4TISCOASSET3UOBAM3BBLAM3
KASSET3
TALISAM3| Fund | MRK weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| SCBIHEALT(SSFE) | 6.49% | BNP Paribas Funds Health Care Innovators | +15.53% | 0.11% |
| LHHEALTH-A | 6.22% | AB International Health Care Portfolio | +18.58% | 2.16% |
| MHEALTHG | 6.03% | BGF World Healthscience Fund | +17.59% | 2.00% |
| MHEALTHRMF | 5.90% | BGF World Healthscience Fund | +18.34% | 1.81% |
| TUSHEALTH-A | 5.77% | XLV | +23.08% | 1.31% |
| UHCRMF | 5.54% | United Global Healthcare Fund | +15.57% | 1.86% |
| UGH | 5.49% | United Global Healthcare Fund | +15.64% | 1.88% |
| UOBSHC | 5.49% | United Global Healthcare Fund | +15.82% | 1.86% |
| BCARERMF | 5.47% | Wellington Global Health Care Equity Fund | +22.64% | 1.48% |
| BCARE | 5.46% | Wellington Global Health Care Equity Fund | +23.02% | 1.24% |
| BCARESSF | 5.43% | Wellington Global Health Care Equity Fund | +22.81% | 1.23% |
| K-GHEALTH | 5.41% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.26% | 1.75% |
| K-GHRMF | 5.41% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.44% | 1.74% |
| KFHHCARE-A | 5.28% | JPMorgan Funds - Global Healthcare Fund | +15.06% | 1.54% |
| KFHCARERMF | 5.26% | JPMorgan Funds - Global Healthcare Fund | +15.68% | 1.54% |
| KFHEALTH-A | 5.25% | JPMorgan Funds - Global Healthcare Fund | +23.48% | 1.53% |
| K-GHEALTH(UH) | 5.14% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +22.56% | 1.76% |
| LHLONGEVITY | 4.78% | CANC | N/A | 2.10% |
| TGHRMF-A | 4.22% | several master funds (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | +20.61% | 1.60% |
| TLUSHD-UH | 4.13% | SCHD | N/A | 1.48% |
| Fund | MRK weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| TLUSHDRMF | 4.09% | SCHD | N/A | 1.48% |
| TLUSHD-H | 4.05% | SCHD | N/A | 1.48% |
| TGHSTARP | 3.66% | several master funds (BlackRock Global Funds - World Healthscience) | +15.44% | 1.90% |
| KFESG-A | 2.56% | AB Sustainable Global Thematic Portfolio | −6.79% | 1.54% |
| KFESGRMF | 2.56% | AB Sustainable Global Thematic Portfolio | −6.95% | 1.59% |
| KFESGSSF | 2.54% | AB Sustainable Global Thematic Portfolio | −6.95% | 1.68% |
 ES-LOVE | 2.40% | Eastspring Investments – Global Low Volatility Equity Fund | +11.38% | 1.26% |
| SCBGHC | 2.38% | Janus Henderson Global Life Sciences Fund | +19.10% | 1.72% |
| KT-HEALTHCARE-A | 2.34% | Janus Henderson Global Life Sciences Fund | +20.31% | 1.34% |
| SCBRMGHC | 2.33% | Janus Henderson Global Life Sciences Fund | +19.18% | 1.18% |
| KT-HEALTHC RMF | 2.33% | Janus Henderson Global Life Sciences Fund | +20.06% | 1.97% |
 KKP GHC-A | 2.32% | Janus Henderson Global Life Sciences Fund | +18.96% | 1.21% |
| ES-HEALTHCARERMF | 2.29% | Janus Henderson Global Life Sciences Fund | +18.85% | 1.78% |
| ES-HEALTHCARE | 2.29% | Janus Henderson Global Life Sciences Fund | +19.67% | 1.24% |
| SCBLEQ | 1.94% | AB Low Volatility Equity Portfolio | +2.32% | 1.71% |
| SCBRMLEQ | 1.93% | AB Low Volatility Equity Portfolio | +2.94% | 1.18% |
| KT-WEQ RMF | 1.92% | AB Low Volatility Equity Portfolio | +2.54% | 1.56% |
| KT-WEQ-A | 1.92% | AB Low Volatility Equity Portfolio | +2.56% | 1.54% |
| JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD |
| 3 |
| 5.41% |
| JPMorgan Funds - Global Healthcare Fund | 3 | 5.28% |
| Schwab U.S. Dividend Equity ETF | 3 | 4.13% |
| AB Sustainable Global Thematic Portfolio | 3 | 2.56% |
| BGF World Healthscience Fund | 2 | 6.03% |
| BNP Paribas Funds Health Care Innovators | 1 | 6.49% |
| AB International Health Care Portfolio | 1 | 6.22% |
| State Street Health Care Select Sector SPDR ETF | 1 | 5.77% |
| Tema Oncology ETF | 1 | 4.78% |
| several master funds (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | 1 | 4.22% |
| several master funds (BlackRock Global Funds - World Healthscience) | 1 | 3.66% |
| 13.0B USD |
| 14.5B USD |
| 365.0M USD |
| 17.1B USD |
| 18.3B USD |
| EPS (diluted) | 5.14 | 5.71 | 0.14 | 6.74 | 7.28 |
| Gross margin | 72.0% | 70.6% | 73.2% | 76.3% | 74.8% |
| Net margin | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% |
| Operating cash flow | N/A | 19.1B USD | 13.0B USD | 21.5B USD | 16.5B USD |
| Free cash flow | N/A | 14.7B USD | 9.1B USD | 18.1B USD | 12.4B USD |
| Total assets | 105.7B USD | 109.2B USD | 106.7B USD | 117.1B USD | 136.9B USD |
| Total liabilities | 67.4B USD | 63.1B USD | 69.0B USD | 70.7B USD | 84.2B USD |
| Shareholders' equity | 38.3B USD | 46.1B USD | 37.6B USD | 46.4B USD | 52.7B USD |
| 127.27 |
| 128.43 |
| Above |
